市場調査レポート

商品コード

1554277

腫瘍アブレーション市場規模、シェア、成長分析：技術別、治療別、用途別、地域別- 産業予測、2024年～2031年

Tumor Ablation Market Size, Share, Growth Analysis, By Technology, By Treatment, By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年09月06日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

腫瘍アブレーションの世界市場規模は、2022年に14億8,000万米ドルと評価され、予測期間（2024-2031年）にCAGR 13.5%で上昇することにより、2023年の16億8,000万米ドルから2031年には46億3,000万米ドルに成長する見通しです。

がんの罹患率の増加と、より安全な治療オプションに対する需要の高まりが、市場成長を促進する主な要因です。世界保健機関（WHO）は、2030年までに世界で毎年1,000万人から1,100万人のがん患者が新たに診断されると予測しています。低所得国では、新たながん症例は80％以上増加すると予想されるのに対し、高所得国では40％の増加です。このようながん患者の急増は、低侵襲・非侵襲の治療オプションに対する強い要望と相まって、今後数年間の大幅な市場拡大を促進すると予想されます。外科医と患者の両方が低侵襲処置を好むことで、先進的な腫瘍アブレーション技術への需要が高まる可能性が高いです。これらの手法には、回復の早さ、患者の快適性の向上、処置時間の短縮といった利点があります。従来の治療とは異なり、先進的アブレーション法は外来で行われることが多く、入院の必要がなく、全体的なヘルスケアコストを削減することができます。アブレーションは特に小さな腫瘍に有効であり、その利用率はがんの発見率と密接に関連しています。しかし、2020年にはCOVID-19の大流行により、検診活動の減少により新たながん診断が大幅に減少したため、市場は顕著な影響を受けた。Our World in Dataの調査によると、がん診断の70％以上が50歳以上で発生しており、この数字は高齢化とともに増加すると予想されています。加齢による身体機能の低下ががんの有病率を高めるため、非侵襲的切除術の需要は拡大すると予想されます。精度、機動性、費用対効果の向上を目指した技術の進歩が、市場の革新を促進しています。冷却ラジオ波焼灼術のような新しい技術は、病変の大きさを改善し、痛みを緩和するために外部から冷却したプローブを使用するもので、市場の今後の拡大において重要な役割を果たすものと思われます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Medtronic plc（Ireland）
Boston Scientific Corporation（US）
Johnson & Johnson（Ethicon, Inc.）（US）
AngioDynamics, Inc.（US）
EDAP TMS S.A.（France）
SonaCare Medical, LLC（US）
Merit Medical Systems, Inc.（US）
Misonix, Inc.（US）
HealthTronics, Inc.（US）
Galil Medical Ltd.（US）
IceCure Medical Ltd.（Israel）
Monteris Medical, Inc.（Canada）
Hologic, Inc.（US）
Symple Surgical Inc.（US）
BVM Medical Limited（UK）
Ablatherm（Esaote S.p.A.）（Italy）
Bioventus LLC（US）
CEVOTEC（Germany）
Fujifilm Holdings Corporation（Japan）
InSightec Ltd.（Israel）
Philips Healthcare（Netherlands）

Product Code: SQMIG35A2494

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

The growing incidence of cancer and the increasing demand for safer therapeutic options are major factors fueling market growth. The World Health Organization (WHO) projects that by 2030, there will be between 10 to 11 million new cancer cases diagnosed globally each year. In low-income countries, new cancer cases are expected to rise by over 80%, compared to a 40% increase in high-income nations. This surge in cancer cases, combined with the strong desire for minimally and non-invasive treatment options, is anticipated to drive significant market expansion in the coming years. The preference for minimally invasive procedures among both surgeons and patients is likely to enhance the demand for advanced tumor ablation techniques. These methods offer advantages such as quicker recovery, improved patient comfort, and shorter procedure times. Unlike traditional treatments, advanced ablation procedures are often performed on an outpatient basis, eliminating the need for hospital admission and reducing overall healthcare costs. Ablation is particularly effective for small tumors, and its utilization is closely linked to cancer detection rates. However, the market experienced a notable impact in 2020, as the COVID-19 pandemic led to a significant reduction in new cancer diagnoses due to decreased screening activities. A survey by Our World in Data highlights that over 70% of cancer diagnoses occur in individuals over 50, a number expected to rise with the aging population. As age-related decline in bodily functions increases the prevalence of cancer, the demand for non-invasive ablation procedures is expected to grow. Technological advancements aimed at improving accuracy, mobility, and cost-effectiveness are driving market innovation. Emerging techniques, such as cooled radiofrequency ablation, which uses externally chilled probes to enhance lesion size and provide pain relief, are poised to play a significant role in the market's future expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tumor Ablation Market Segmental Analysis

The global tumor ablation market is segmented by technology, application, treatment, and region. Based on technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, High-intensity-focused Ultrasound (HIFU), and other ablation technologies. Based on treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. Based on application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Based on end users, the market is segmented into Hospitals & Clinics, Cancer Care Centers, and other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Tumor Ablation Market

The increasing global incidence of cancer, especially lung, liver, kidney, and breast cancers, is significantly driving the growth of the tumor ablation market. Tumor ablation techniques are gaining prominence as they provide minimally invasive alternatives to traditional surgery, offering effective treatment options for localized tumors. These methods are particularly valuable for patients who may not be eligible for conventional surgical procedures. By offering less invasive treatment options, tumor ablation techniques address a critical need in the oncology field. They present a viable solution for patients with localized tumors, allowing for effective management of cancer while minimizing the risks and recovery times associated with more invasive surgical interventions.

Restraints in the Global Tumor Ablation Market

Tumor ablation procedures can be costly, particularly when advanced technologies and imaging guidance are used. The high expenses associated with specialized equipment, consumables, and skilled healthcare professionals can restrict access to these treatments, especially in resource-limited regions and developing countries. The financial burden of these procedures can limit their availability and make them less accessible to patients in areas with constrained healthcare resources. This cost factor poses a significant challenge to the widespread adoption of tumor ablation techniques across diverse healthcare settings.

Market Trends of the Global Tumor Ablation Market

The tumor ablation market is experiencing ongoing technological progress, resulting in the emergence of more sophisticated and precise ablation techniques. Innovations include the incorporation of imaging technologies for real-time guidance, the application of robotic systems to boost precision, and the introduction of novel energy sources for ablation. These advancements contribute to improved efficacy and safety in tumor ablation procedures. As technology continues to evolve, these developments are significantly enhancing the effectiveness of tumor ablation treatments. The integration of advanced imaging and robotic systems, along with new energy modalities, ensures greater accuracy and safety during procedures, thereby improving overall patient outcomes.

Introduction

Objectives of the study
Definitions
Market scope

Research methodology

Information procurement
Secondary & primary data sources
Market size estimation
Market assumptions & limitations

Executive summary

Market overview outlook
Supply demand trend analysis
Segmental opportunity analysis

Market dynamics & outlook

Market dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters' analysis
- Competitive rivalry
- Threat of substitute products
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key market insights

Key success factors of the market
Value chain analysis
Top investment pockets
Market attractive index
Ecosystem mapping
Pricing analysis
Patent Analysis
Porter's five forces analysis
Trade analysis
Supply chain analysis
Regulatory analysis
Technology analysis
Case study analysis

Global Tumor Ablation Market by Technology

Market overview
Radiofrequency ablation
Microwave ablation
Cryoablation
Irreversible electroporation ablation
High-intensity-focused Ultrasound (HIFU)
Other ablation technologies

Global tumor ablation market by Treatment

Market overview
Surgical ablation
Laparoscopic ablation
Percutaneous ablation

Global tumor ablation market by Application

Market overview
Kidney cancer
Liver cancer
Breast cancer
Lung cancer
Prostate cancer
Other cancer

Global tumor ablation market by Product Type

Market overview
Generators
Probes/electrodes
- Radiofrequency Ablation Probes
- Microwave Ablation Probes
- Other Probes/Electrodes

Global tumor ablation market by End Use

Market overview
Hospitals & Clinics
Cancer Care Centers
Other End Users

Global tumor ablation market size by Region

Market overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-pacific
Latin America
- Brazil
- Rest of Latin America
Middle east & Africa (MEA)
- GCC countries
- South Africa
- Rest of MEA

Competitive landscape

Top 5 player comparison
Market positioning of key players, 2023
Strategies adopted by key market players
Recent activities in the market
Key companies market share (%), 2023

Key company profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (Ethicon, Inc.) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EDAP TMS S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonaCare Medical, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Misonix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HealthTronics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galil Medical Ltd. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IceCure Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monteris Medical, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Symple Surgical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BVM Medical Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ablatherm (Esaote S.p.A.)(Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CEVOTEC (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSightec Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

腫瘍アブレーション市場規模、シェア、成長分析：技術別、治療別、用途別、地域別- 産業予測、2024年～2031年

Tumor Ablation Market Size, Share, Growth Analysis, By Technology, By Treatment, By Application, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

腫瘍アブレーション市場：技術別

腫瘍アブレーション市場：治療別

腫瘍アブレーション市場：用途別

腫瘍アブレーション市場：製品タイプ別

腫瘍アブレーション市場：エンドユーザー別

腫瘍アブレーション市場規模：地域別